Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

Teva Metformin Recall Lawsuit

tsf-no-longer-accepting-cases

Teva Pharmaceuticals recalled 14 lots of the diabetes drug metformin (Actavis® Metformin ER) due to high levels of a cancer-causing chemical called NDMA.

Teva Pharmaceuticals Recalls Metformin for High Levels of Cancer-Causing Chemicals

In June 2020, Teva Pharmaceuticals USA, Inc. issued a recall for 14 lots of Actavis® Metformin Extended-Release (500-mg and 750-mg) after FDA tests found unsafe levels of a cancer-causing chemical.

Diabetes Drugs Linked to Cancer Risk

The recalled metformin was contaminated with a chemical called N-Nitrosodimethylamine (NDMA). This chemical is believed to cause cancer in humans. Patients on metformin may be at risk of cancer because they were exposed to NDMA every day while taking these recalled diabetes medications.

Was My Metformin ER Recalled?

Teva Pharmaceuticals recalled 14 lots of Actavis® Metformin Extended-Release (Metformin ER) medications that were distributed nationwide between January 8, 2019 and May 27, 2020 in bottles of 100 or 1000 tablets.

List of Metformin Drugs Recalled by Teva Pharmaceuticals for NDMA Contamination

NDC Product Description Lot Number Expiration
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1329548A 06/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1338302M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348968M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348969M 11/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1348970M 10/2020
62037-571-01 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 100 Count 1376339M 09/2021
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1323460M 06/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1330919M 06/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1338300A 10/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1341135M 12/2020
62037-571-10 Metformin Hydrochloride Extended-Release Tablets, USP 500 mg 1000 Count 1391828M 11/2021
62037-577-01 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 100 Count 1333338M 08/2020
62037-577-01 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 100 Count 1333339A 08/2020
62037-577-10 Metformin Hydrochloride Extended-Release Tablets, USP 750 mg 1000 Count 1354471A 02/2021

Types of Cancer Linked to NDMA

  • Liver cancer
  • Kidney cancer
  • Intestinal cancer
  • Stomach cancer
  • Pancreatic cancer
  • Colon cancer
  • Esophageal cancer
  • Ovarian cancer
  • Testicular cancer
  • Bladder cancer
  • And more

Free Case Evaluation


The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.